Ronaldo Invested $7.5 Million in Herbalife Subsidiary

The athlete took a 10% stake in HBL Pro2col Software, a move deepening his long-term partnership with the nutrition firm.

Updated on Sept. 29, 2026 in Healthcare

Isometric editorial illustration of modular cubic data blocks representing health technology software, with clean geometric shapes.
Cristiano Ronaldo has acquired a 10% stake in HBL Pro2col Software LLC, an Herbalife health-technology subsidiary, for $7.5 million. AI Illustration. Upload story photo >

Live Poll

Do you think it is a good idea for athletes to become stakeholders in their sponsors?

In February 2026, Cristiano Ronaldo invested $7.5 million for a 10% equity stake in HBL Pro2col Software LLC, a subsidiary of Herbalife. The deal marks a strategic expansion of his role as a brand ambassador for the nutrition company, which has partnered with the athlete since 2013.

Why it matters

The investment ties one of the world's highest-earning athletes more closely to the health-tech operations of a firm that has historically faced significant regulatory scrutiny. The deal coincides with a period where Herbalife is working to stabilize its business after years of stock decline and public legal challenges.

Ronaldo invested $7.5 million for a 10% stake in HBL Pro2col, while Herbalife reported a 6.3% increase in fourth-quarter 2025 sales versus 1% growth for the full year. The announcement drove a 15% rise in Herbalife's stock price, which had previously fallen by roughly two-thirds over five years.

The players

Cristiano Ronaldo

A professional athlete who earned $280 million in 2025 and serves as a long-term brand ambassador for Herbalife.

Herbalife

A global multi-level marketing company that sells nutrition and weight-management products.

HBL Pro2col Software LLC

A health-tech subsidiary of Herbalife that develops software for personalized wellness planning.

The details

The investment provides capital to HBL Pro2col Software LLC, a subsidiary focused on a health-tech platform that generates personalized wellness plans. The platform operates by leveraging user-supplied health and lifestyle information to drive engagement. This capital infusion integrates Ronaldo’s personal brand more deeply into the company's tech-driven product development cycle.

Timeline

  1. 2013: Ronaldo became a global brand ambassador for Herbalife.

  2. 2016: Herbalife settled with the FTC for $200 million.

  3. Q4 2025: Herbalife sales increased by 6.3%.

  4. February 2026: The investment deal was disclosed.

Market Landscape

This move highlights a pivot toward digital integration following the company's 2016 FTC settlement, which required a significant $200 million payment. The investment follows a pattern of legacy multi-level marketing firms attempting to modernize through tech-led health platforms.

Operators should observe how Herbalife utilizes this capital infusion to scale its wellness platform, particularly how personalized digital data can drive customer retention in nutrition markets. Watch for whether this high-profile endorsement impacts broader consumer trust metrics for the brand.

The takeaway

The investment illustrates how brands leverage existing celebrity partnerships to pivot into new tech verticals. Operators should track how equity-linked brand ambassadors influence long-term consumer loyalty and stock volatility in mature market categories.

Further reading

For broader trends in industry-led health innovation, see the latest updates in Healthcare.

Source note: This article includes information reported by The Times of India.

Live Poll

Do you think it is a good idea for athletes to become stakeholders in their sponsors?